4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-22-018941
Chief Financial Officer bought 75,000 shares at $2.08 ($156,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Alspaugh Jonathan Chief Financial Officer | 2022-03-11 | Purchase | +75,000 | $2.08 | $156,000 | 165,372 | D |
| Open-market purchases · 75,000 sh · avg $2.08 · $156,000 | |||||||
Loading xslF345X03/doc4.xml…